{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:36Z","timestamp":1760059956517,"version":"build-2065373602"},"reference-count":9,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>For many decades, conventional pharmaceutical excipients have been used to optimize the palatability, processing ability, flowability, and compressibility of various types of medication throughout the production process [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics17080978","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:50:03Z","timestamp":1753714203000},"page":"978","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biofunctional Pharmaceutical Additives for Targeted, Improved Bioavailability and Safety of Medicine"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-5143","authenticated-orcid":false,"given":"Hamdy","family":"Abdelkader","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4608-5949","authenticated-orcid":false,"given":"Adel Al","family":"Fatease","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9777-0674","authenticated-orcid":false,"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Auckland, Auckland 1010, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Qelliny, M., Mustafa, W., Al Fatease, A., Alamri, A., Alany, R., and Abdelkader, H. (2025). Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17050598"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejps.2015.12.018","article-title":"Pharmaceutical excipients\u2014Quality, regulatory and biopharmaceutical considerations","volume":"87","author":"Elder","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_3","unstructured":"Adejare, A. (2021). Chapter 32\u2014Pharmaceutical excipients. Remington, Academic Press. [23rd ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.xphs.2016.03.019","article-title":"An Overview of Pharmaceutical Excipients: Safe or Not Safe?","volume":"105","author":"Abrantes","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2014.05.022","article-title":"A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug","volume":"62","author":"ElShaer","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/pharmaceutics4010179","article-title":"Preparation and Characterization of Amino Acids-Based Trimethoprim Salts","volume":"4","author":"ElShaer","year":"2012","journal-title":"Pharmaceutics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/156720111795767924","article-title":"Use of Amino Acids as Counterions Improves the Solubility of the BCS II Model Drug, Indomethacin","volume":"8","author":"ElShaer","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kasal, P., and Jind\u0159ich, J. (2021). Mono-6-Substituted Cyclodextrins\u2014Synthesis and Applications. Molecules, 26.","DOI":"10.3390\/molecules26165065"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/elps.201900065","article-title":"Synthesis of the chiral selector heptakis(6-O-methyl)-\u03b2-cyclodextrin by phase-transfer catalysis and hydrazine-mediated transfer-hydrogenation","volume":"40","author":"Darcsi","year":"2019","journal-title":"Electrophoresis"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/978\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:17Z","timestamp":1760033837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["pharmaceutics17080978"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17080978","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}